BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 17950782)

  • 1. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene mutation analysis in five cases of dermatofibrosarcoma protuberans using formalin-fixed, paraffin-embedded tissues.
    Saeki H; Tsunemi Y; Ohtsuki M; Kikuchi K; Tamaki K
    Acta Derm Venereol; 2005; 85(3):221-4. PubMed ID: 16040406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.
    Sheng WQ; Hashimoto H; Okamoto S; Ishida T; Meis-Kindblom JM; Kindblom LG; Hisaoka M
    J Pathol; 2001 May; 194(1):88-94. PubMed ID: 11329146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans.
    Saeki H; Tamada Y; Watanabe D; Akita Y; Matsumoto Y; Imai C; Kadono T; Maekawa T; Hattori N; Watanabe A; Torii H; Tamaki K
    Clin Exp Dermatol; 2006 May; 31(3):441-4. PubMed ID: 16681596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.
    Sirvent N; Maire G; Pedeutour F
    Genes Chromosomes Cancer; 2003 May; 37(1):1-19. PubMed ID: 12661001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of dermatofibrosarcoma protuberans: a comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies.
    Salgado R; Llombart B; M Pujol R; Fernández-Serra A; Sanmartín O; Toll A; Rubio L; Segura S; Barranco C; Serra-Guillén C; Yébenes M; Salido M; Traves V; Monteagudo C; Sáez E; Hernández T; de Álava E; Llombart-Bosch A; Solé F; Guillén C; Espinet B; López-Guerrero JA
    Genes Chromosomes Cancer; 2011 Jul; 50(7):510-7. PubMed ID: 21484928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel fusion gene of collagen type I alpha 1 (exon 31) and platelet-derived growth factor B-chain (exon 2) in dermatofibrosarcoma protuberans.
    Nakanishi G; Lin SN; Asagoe K; Suzuki N; Matsuo A; Tanaka R; Makino E; Fujimoto W; Iwatsuki K
    Eur J Dermatol; 2007; 17(3):217-9. PubMed ID: 17478383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinicopathological analysis of dermatofibrosarcoma protuberans.
    Walluks K; Chen Y; Woelfel C; Yang L; Cui T; Seliger C; Geier C; Knösel T; Hauke S; Petersen I
    Pathol Res Pract; 2013 Jan; 209(1):30-5. PubMed ID: 23207290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
    Szollosi Z; Scholtz B; Egervari K; Nemes Z
    J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
    Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
    Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.
    Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H
    Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic gains of COL1A1-PDFGB occur in the histologic evolution of giant cell fibroblastoma into dermatofibrosarcoma protuberans.
    Macarenco RS; Zamolyi R; Franco MF; Nascimento AG; Abott JJ; Wang X; Erickson-Johnson MR; Oliveira AM
    Genes Chromosomes Cancer; 2008 Mar; 47(3):260-5. PubMed ID: 18069662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation.
    Swaby MG; Evans HL; Fletcher CD; Prieto VG; Patel KU; Lev DC; Lòpez-Terrada D; Lazar AJ; Wang WL
    Am J Dermatopathol; 2011 Jun; 33(4):354-60. PubMed ID: 21478726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
    Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
    Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A clinical, histologic, and molecular study of 9 cases of congenital dermatofibrosarcoma protuberans.
    Maire G; Fraitag S; Galmiche L; Keslair F; Ebran N; Terrier-Lacombe MJ; de Prost Y; Pedeutour F
    Arch Dermatol; 2007 Feb; 143(2):203-10. PubMed ID: 17310000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COL1A1:PDGFB chimeric transcripts are not present in indeterminate fibrohistiocytic lesions of the skin.
    Wang WL; Patel KU; Coleman NM; Smith-Zagone MJ; Ivan D; Reed JA; López-Terrada D; Lazar AJ; Prieto VG
    Am J Dermatopathol; 2010 Apr; 32(2):149-53. PubMed ID: 19940748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR.
    Gökden N; Dehner LP; Zhu X; Pfeifer JD
    J Cutan Pathol; 2003 Mar; 30(3):190-5. PubMed ID: 12641779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.
    Segura S; Salgado R; Toll A; Martín-Ezquerra G; Yébenes M; Sáez A; Solé F; Barranco C; Umbert P; Espinet B; Pujol RM
    Hum Pathol; 2011 Feb; 42(2):176-84. PubMed ID: 21111450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.